Received Apr 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 447N4 | — |
received a dose of Priorix that had expired; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a male patient who received MMR (Priorix) (batch number 447N4, expiry date 11-MAY-2024) for prophylaxis. On 21-MAR-2025, the patient received Priorix. On 21-MAR-2025, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: received a dose of Priorix that had expired). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 24-MAR-2025 The nursing supervisor reported that a patient received a dose of Priorix that had expired, which led to expired vaccine used. The Vaccine Administration Facility was the same as Primary Reporter.